Skip to main content
Clinical Trials/JPRN-UMIN000032716
JPRN-UMIN000032716
Completed
N/A

The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors regorafenib - The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors regorafenib

Japanese Foundation For Cancer Research0 sites16 target enrollmentJuly 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Colorectal cancer
Sponsor
Japanese Foundation For Cancer Research
Enrollment
16
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2018
End Date
July 1, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with fissure or erosion in the palmoplantar area 2\) Patients with a history of sympathectomy

Outcomes

Primary Outcomes

Not specified

Similar Trials